Medical and Pharmaceutical Median Technologies partners with Canon Medical to achieve lung cancer screening goals Their collaboration seeks to expedite deployment of Median's AI-powered nodule detection system Rowan Dunne1 day ago
AI and Autonomy Four tech startups turning to Regulation Crowdfunding: A Mugglehead roundup The system makes it easier for smaller companies to access capital while preserving investor protections Joseph MortonJuly 23, 2026
Medical and Pharmaceutical Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test The CIZ1B test is meant to complement LDCT in detecting early-stage disease Rowan DunneJuly 23, 2026
Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
Medical and Pharmaceutical AI-powered light scan could speed up targeted lung cancer treatments This technique, fluorescence lifetime imaging microscopy, could save patients and hospitals alot of money Rowan DunneJuly 13, 2026
Medical and Pharmaceutical MIT continues advancing ‘PlasmoSniff’ pneumonia breath test The prestigious school is one of a select few active with breath sampling tech for this infection Rowan DunneJune 25, 2026
Medical and Pharmaceutical Pigeons help prevent radiologists from missing malignancies on CT scans This is not the first time these 'flying rats' have shown they can assist with cancer screening Rowan DunneJune 23, 2026
AI and Autonomy AI helps NHS cut lung cancer scan review times in half The government said AI-powered X-ray tools are already available in roughly half of NHS trusts across England Joseph MortonJune 19, 2026
Medical and Pharmaceutical Micro-X and University of Sydney undertake mini lung CT scanner research They have secured AUD$1.9 million for their project Rowan DunneJune 18, 2026
AI and Autonomy Five technologies moving from science fiction to reality: A Mugglehead roundup The goal is to solve longstanding problems that have resisted traditional approaches Joseph MortonJune 12, 2026